Cell Stem Cell
Volume 14, Issue 2, 6 February 2014, Pages 139-140
LetterDiffering Standards for the NIH Stem Cell Registry and FDA Approval Render Most Federally Funded hESC Lines Unsuitable for Clinical Use
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2014 Elsevier Inc. All rights reserved.